Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
PromarkerD
Biotech Stocks Healthcare Stocks Market news Mid Cap Stocks News Small Caps Stocks
Proteomics’ PromarkerD test for DKD has been launched in Australia, and two more tests will launch later in 2025
2025 has been, and will continue to be, a big year for Proteomics, which has just launched PromarkerD onto the Australian market. Before this year is over, the company anticipates launching another 2 tests - PromarkerEndo and PromarkerEso; and is eyeing off the US market too.  Recap of Proteomics (ASX:PIQ) For investors that are new to…
May 28, 20250Comments
buy Apple shares from Australia
Blue Chip Stocks Dividend Stocks General International Stocks Large Caps Tech Stocks Technology
Should I buy Apple shares from Australia? Can the US$3.3tn behemoth grow any further?
Investors asking themselves, 'Should I buy Apple shares from Australia,' are not just considering buying shares any company, but the world's largest. Capped at over $3tn, the Silicon Valley-based tech (and arguably luxury) company has risen to spectacular new heights since the departure and death of Steve Jobs, surpassing $1tn in August 2018, $2tn in…
May 28, 20250Comments
Will Ozempic hurt healthcare stocks
Education General Healthcare Stocks Industrials Large Caps Life Sciences
Will Ozempic hurt healthcare stocks? Here are 5 reasons we don’t think so
Will Ozempic hurt healthcare stocks? Investors who've been selling healthcare stocks left right and centre - except Novo Nordisk of course, now the largest stock in Europe by market capitalisation - believe it will. But even though we hear these arguments loud and clear, we think these fears are overblown.Ozempic is a weight-loss drug that…
May 28, 20250Comments
Ventia
Blue Chip Stocks Industrials Large Caps News
Why Ventia (ASX: VNT) has more than doubled since its late 2021 listing – second time lucky!
Ventia Services (ASX:VNT) listed on the ASX in November 2021 at $1.5bn and is now capitalised at $4bn. Since listing it has recorded persistent revenue and profit growth. There is very little to complain about from a financial perspective, and it may still be undervalued. However, things aren't completely perfect for it.  Overview of Ventia…
May 27, 20250Comments
ESG Investing
Bank Stocks CleanTech Consumer Education Healthcare Stocks Index Funds Life Sciences Market news News Real Estate Technology Undervalued Stocks
ESG Investing in 2025: How can I tell if a stock or fund is ethical or ESG compliant?
ESG investing is becoming increasingly popular with investors. But as this happens, it begs the question as to just how you can tell if an applicable stock or fund is ESG friendly?  So how can I tell if my stock or fund is ESG compliant? As tough as it is to disappoint our readers, there is no…
May 26, 20250Comments
Nufarm
Agriculture Stocks Blue Chip Stocks Large Caps Mid Cap Stocks
Nufarm (ASX:NUF): Hit by lower commodity prices, adverse weather and Trump’s tariffs
Have some sympathy for Nufarm (ASX:NUF). Companies capped at over $1bn rarely plunge 30% after reporting results unless the results (or the outlook) were bad enough to warrant it, and this is just what happened earlier this week.  Introduction to Nufarm (ASX:NUF) Nufarm is an agricultural chemical supplier and manufacturer - its most important is omega-3…
May 23, 20250Comments

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here